Topiramate-Induced Oral Lichenoid Lesions: A Case Report (Case Report)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Elyasi Forouzan; REZAEI MAEDEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Iranian Medical Council Year:2022 | Volume:5 | Issue:3 Page(s): 527-531

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Topiramate-Induced Oral Lichenoid Lesions: A Case Report (Case Report)

Author(s)

Elyasi Forouzan | REZAEI MAEDEH | Issue Writer Certificate

Keywords

Case report

Diagnosis

Lichenoid lesion

Oral

Side effects

Topiramate

Abstract

Topiramate is being widely used to prevent migraine headaches and treat epilepsy and mental disorders,however, Oral Lichenoid lesion (OLL) is one of its rare Side effects. The present report has been provided based on a patient case study who had developed OLLs following treatment with Topiramate. The patient was a 50-year-old woman referred to a psychiatric clinic with complaints of severe headaches, anxiety, insomnia, and symptoms of Obsessive-Compulsive Disorder (OCD). For this purpose, fluoxetine, Topiramate, and nortriptyline were prescribed. Two months after increasing the Topiramate dosage to 400 mg per day, she developed OLLs. The Topiramate dose was reduced within two weeks and finally discontinued. The lesions were removed four weeks after the cessation. The patient had no lesions for 6 months. With restarting the drug, the lesion reappeared and finally, ceasing Topiramate usage. To conclude, the mentioned lesions are one of the rare complications of this anticonvulsant drug.

Cites

No record.

References

No record.

Cite

APA: Copy

Elyasi, Forouzan, & REZAEI, MAEDEH. (2022). Topiramate-Induced Oral Lichenoid Lesions: A Case Report (Case Report). JOURNAL OF IRANIAN MEDICAL COUNCIL, 5(3), 527-531. SID. https://sid.ir/paper/1145394/en

Vancouver: Copy

Elyasi Forouzan, REZAEI MAEDEH. Topiramate-Induced Oral Lichenoid Lesions: A Case Report (Case Report). JOURNAL OF IRANIAN MEDICAL COUNCIL[Internet]. 2022;5(3):527-531. Available from: https://sid.ir/paper/1145394/en

IEEE: Copy

Forouzan Elyasi, and MAEDEH REZAEI, “Topiramate-Induced Oral Lichenoid Lesions: A Case Report (Case Report),” JOURNAL OF IRANIAN MEDICAL COUNCIL, vol. 5, no. 3, pp. 527–531, 2022, [Online]. Available: https://sid.ir/paper/1145394/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops